Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Case Report

Post-surgical Persistent Hyperparathyroidism Successfully Treated with Parathyroid Radiofrequency Ablation: A Case Report

In Press, (this is not the final "Version of Record"). Available online 26 April, 2024
Author(s): Francesco Di Marco*, Claudio Cusini, Anna Ferrulli, Giovanni Mauri and Livio Luzi
Published on: 26 April, 2024

DOI: 10.2174/0118715303308277240419062634

Price: $95

Abstract

Background: Currently, parathyroidectomy is the standard treatment for Primary Hyperparathyroidism (PHPT). Surgical treatment is often effective, although not free of complications and relapses. Minimally invasive techniques, such as Microwave Ablation (MWA) and Radiofrequency Ablation (RFA), are an alternative to surgery in selected patients. We have, herein, reported on the successful use of RFA in a patient with post-surgical persistent hyperparathyroidism.

Case Presentation: A 54-year-old woman was referred to our Center for mild hypercalcemia with exams revealing Primary Hyperparathyroidism (PHPT). Neck ultrasound and Technetium- 99 Methoxy-isobutyl-isonitrile (99mTc-MIBI) scintigraphy scanning revealed a suspicious right parathyroid hyperplasia/adenoma. She underwent parathyroidectomy and histological examination showed a parathyroid nodular hyperplasia. During the follow-up, she suffered from persistent hyperparathyroidism due to the treatment of left parathyroid hypoplasia with RFA. Blood tests after the procedure showed the remission of the disease 7 months post-treatment.

Conclusion: A minimally invasive technique for PHPT may represent a valid alternative to surgery, especially in patients with an elevated surgery-related risk. More studies are necessary to investigate the benefit of RFA as a first-line treatment in PHPT.

[1]
Marcocci, C.; Cetani, F. Primary hyperparathyroidism. Encycl. Endocr. Dis, 2018, 128-138.
[http://dx.doi.org/10.1016/B978-0-12-801238-3.65217-0]
[2]
Hamdy, N.A.T. Parathyroid gland: Is parathyroidectomy safe and beneficial in the elderly? Nat. Rev. Endocrinol., 2009, 5(8), 422-423.
[http://dx.doi.org/10.1038/nrendo.2009.142] [PMID: 19629065]
[3]
Caron, N.R.; Sturgeon, C.; Clark, O.H. Persistent and recurrent hyperparathyroidism. Curr. Treat. Options Oncol., 2004, 5(4), 335-345.
[http://dx.doi.org/10.1007/s11864-004-0024-4] [PMID: 15233910]
[4]
Nawrot, I.; Chudziński, W.; Ciąćka, T.; Barczyński, M.; Szmidt, J. Reoperations for persistent or recurrent primary hyperparathyroidism: Results of a retrospective cohort study at a tertiary referral center. Med. Sci. Monit., 2014, 20, 1604-1612.
[http://dx.doi.org/10.12659/MSM.890983] [PMID: 25201515]
[5]
Wei, Y.; Peng, C-Z.; Wang, S-R.; He, J-F.; Peng, L-L.; Zhao, Z-L.; Cao, X-J.; Li, Y.; Yu, M-A. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: A multicenter study. J. Clin. Endocrinol. Metab., 2021, 106(9), 2707-2717.
[http://dx.doi.org/10.1210/clinem/dgab240] [PMID: 33846740]
[6]
Walker, M.D.; Silverberg, S.J. Primary hyperparathyroidism. Nat. Rev. Endocrinol., 2018, 14(2), 115-125.
[http://dx.doi.org/10.1038/nrendo.2017.104] [PMID: 28885621]
[7]
Marcocci, C.; Saponaro, F. Epidemiology, pathogenesis of primary hyperparathyroidism: Current data. Ann. Endocrinol., 2015, 76(2), 113-115.
[http://dx.doi.org/10.1016/j.ando.2015.03.015] [PMID: 25916761]
[8]
Yeh, M.W.; Ituarte, P.H.G.; Zhou, H.C.; Nishimoto, S.; Liu, I.L.; Harari, A.; Haigh, P.I.; Adams, A.L. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab., 2013, 98(3), 1122-1129.
[http://dx.doi.org/10.1210/jc.2012-4022] [PMID: 23418315]
[9]
Griebeler, M.L.; Kearns, A.E.; Ryu, E.; Hathcock, M.A.; Melton, L.J., III; Wermers, R.A. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone, 2015, 73, 1-7.
[http://dx.doi.org/10.1016/j.bone.2014.12.003] [PMID: 25497786]
[10]
Silverberg, S.J.; Shane, E.; Jacobs, T.P.; Siris, E.; Bilezikian, J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med., 1999, 341(17), 1249-1255.
[http://dx.doi.org/10.1056/NEJM199910213411701] [PMID: 10528034]
[11]
Bilezikian, J.P.; Brandi, M.L.; Eastell, R.; Silverberg, S.J.; Udelsman, R.; Marcocci, C.; Potts, J.T., Jr Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab., 2014, 99(10), 3561-3569.
[http://dx.doi.org/10.1210/jc.2014-1413] [PMID: 25162665]
[12]
Guerin, C.; Paladino, N.C.; Lowery, A.; Castinetti, F.; Taieb, D.; Sebag, F. Persistent and recurrent hyperparathyroidism. Updates Surg., 2017, 69(2), 161-169.
[http://dx.doi.org/10.1007/s13304-017-0447-7] [PMID: 28434176]
[13]
Richards, M.L.; Thompson, G.B.; Farley, D.R.; Grant, C.S. Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am. J. Surg., 2008, 196(6), 937-942.
[http://dx.doi.org/10.1016/j.amjsurg.2008.07.022] [PMID: 19095113]
[14]
Kim, B.S.; Eom, T.I.; Kang, K.H.; Park, S.J. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J. Med. Ultrason., 2014, 41(2), 239-243.
[http://dx.doi.org/10.1007/s10396-013-0501-0] [PMID: 27277780]
[15]
Xu, S.Y.; Wang, Y.; Xie, Q.; Wu, H.Y. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singapore Med. J., 2013, 54(7), e137-e140.
[http://dx.doi.org/10.11622/smedj.2013092] [PMID: 23900476]
[16]
Mauri, G.; Gennaro, N.; Lee, M.K.; Baek, J.H. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int. J. Hyperthermia, 2019, 36(2), 13-20.
[http://dx.doi.org/10.1080/02656736.2019.1622795] [PMID: 31537159]
[17]
Ebrahiminik, H.; Chegeni, H.; Mosadegh Khah, A.; Salouti, R.; Ghomashchi, G.; Deldar Pasikhani, M.; Heydari, I.; Shamsi, K.; Beiranvand, B.; Azimi Aval, M.R.; Mohammadi, A.; Mirza-Aghazadeh-Attari, M.; Fadaee, N. Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: A report of 27 patients. J. Clin. Ultrasound, 2022, 50(4), 540-546.
[http://dx.doi.org/10.1002/jcu.23181] [PMID: 35278235]
[18]
Peng, C.Z.; Chai, H.H.; Zhang, Z.X.; Hu, Q.H.; Zeng, Z.; Cui, A.L.; Pang, H.S.; Ruan, L.T. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation. Int. J. Hyperthermia, 2022, 39(1), 490-496.
[http://dx.doi.org/10.1080/02656736.2022.2047231] [PMID: 35285391]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy